Peter S. Kim's most recent trade in Entrada Therapeutics Inc was a trade of 19,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 11, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Entrada Therapeutics Inc | Peter S. Kim | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 19,000 | 19,000 | - | - | Stock Option (Right to Buy) | |
| Littelfuse, Inc. | Sung-Jip Peter Kim | SVP & GM Industrial Business | Grant, award, or other acquisition of securities at price $ 214.14 per share. | 05 Jun 2025 | 7 | 10,163 (0%) | 0% | 214.1 | 1,499 | Common Stock |
| Littelfuse, Inc. | Sung-Jip Peter Kim | SVP & GM Industrial Business | Payment of exercise price or tax liability using portion of securities received from the company at price $ 176.06 per share. | 25 Apr 2025 | 151 | 10,334 (0%) | 0% | 176.1 | 26,585 | Common Stock |
| Littelfuse, Inc. | Sung-Jip Peter Kim | SVP & GM Industrial Business | Payment of exercise price or tax liability using portion of securities received from the company at price $ 176.06 per share. | 25 Apr 2025 | 104 | 10,230 (0%) | 0% | 176.1 | 18,310 | Common Stock |
| Littelfuse, Inc. | Sung-Jip Peter Kim | SVP & GM Industrial Business | Payment of exercise price or tax liability using portion of securities received from the company at price $ 179.04 per share. | 25 Apr 2025 | 74 | 10,156 (0%) | 0% | 179.0 | 13,249 | Common Stock |
| Littelfuse, Inc. | Sung-Jip Peter Kim | SVP & GM Industrial Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Apr 2025 | 2,163 | 10,485 (0%) | 0% | 0 | Common Stock | |
| Littelfuse, Inc. | Sung-Jip Peter Kim | SVP & GM Industrial Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2025 | 4,253 | 8,322 (0%) | 0% | 0 | Common Stock | |
| Entrada Therapeutics Inc | Peter S. Kim | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 16,000 | 16,000 | - | - | Stock Option (Right to Buy) | |
| Entrada Therapeutics Inc | Peter S. Kim | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 11,918 | 0 | - | - | Stock Option (Right to Buy) | |
| Entrada Therapeutics Inc | Peter S. Kim | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.06 per share. | 03 Jun 2024 | 11,918 | 104,330 | - | 6.1 | 72,223 | Common Stock |
| Entrada Therapeutics Inc | Peter S. Kim | Director | Purchase of securities on an exchange or from another person at price $ 14.59 per share. | 14 May 2024 | 25,000 | 92,412 | - | 14.6 | 364,673 | Common Stock |
| Entrada Therapeutics Inc | Peter S. Kim | Director | Purchase of securities on an exchange or from another person at price $ 14.59 per share. | 13 May 2024 | 25,000 | 117,412 | - | 14.6 | 364,673 | Common Stock |
| Entrada Therapeutics Inc | Peter S. Kim | Director | Purchase of securities on an exchange or from another person at price $ 14.68 per share. | 13 May 2024 | 25,000 | 92,412 | - | 14.7 | 367,010 | Common Stock |
| Entrada Therapeutics Inc | Peter S. Kim | Director | Purchase of securities on an exchange or from another person at price $ 14.04 per share. | 08 May 2024 | 2,276 | 65,212 | - | 14.0 | 31,965 | Common Stock |
| Entrada Therapeutics Inc | Peter S. Kim | Director | Purchase of securities on an exchange or from another person at price $ 14.25 per share. | 08 May 2024 | 2,200 | 67,412 | - | 14.2 | 31,341 | Common Stock |
| Littelfuse, Inc. | Sung-Jip Peter Kim | SVP & GM Industrial Business | Payment of exercise price or tax liability using portion of securities received from the company at price $ 231.64 per share. | 27 Apr 2024 | 105 | 4,143 (0%) | 0% | 231.6 | 24,322 | Common Stock |
| Littelfuse, Inc. | Sung-Jip Peter Kim | SVP & GM Industrial Business | Payment of exercise price or tax liability using portion of securities received from the company at price $ 231.64 per share. | 27 Apr 2024 | 74 | 4,069 (0%) | 0% | 231.6 | 17,141 | Common Stock |
| Littelfuse, Inc. | Sung-Jip Peter Kim | SVP & GM Industrial Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Apr 2024 | 4,568 | 4,568 | - | - | Stock Option (right to buy) | |
| Littelfuse, Inc. | Sung-Jip Peter Kim | SVP & GM Industrial Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Apr 2024 | 1,552 | 4,248 (0%) | 0% | 0 | Common Stock | |
| Littelfuse, Inc. | Sung-Jip Peter Kim | SVP & GM Industrial Business | Payment of exercise price or tax liability using portion of securities received from the company at price $ 228.85 per share. | 22 Apr 2024 | 46 | 2,696 (0%) | 0% | 228.8 | 10,527 | Common Stock |
| Entrada Therapeutics Inc | Peter S. Kim | Director | Purchase of securities on an exchange or from another person at price $ 13.57 per share. | 08 Apr 2024 | 2,600 | 62,936 | - | 13.6 | 35,290 | Common Stock |
| Entrada Therapeutics Inc | Peter S. Kim | Director | Purchase of securities on an exchange or from another person at price $ 13.75 per share. | 28 Mar 2024 | 1,512 | 60,336 | - | 13.8 | 20,794 | Common Stock |
| Entrada Therapeutics Inc | Peter S. Kim | Director | Purchase of securities on an exchange or from another person at price $ 13.36 per share. | 22 Mar 2024 | 3,180 | 56,074 | - | 13.4 | 42,472 | Common Stock |
| Entrada Therapeutics Inc | Peter S. Kim | Director | Purchase of securities on an exchange or from another person at price $ 13.76 per share. | 22 Mar 2024 | 3,118 | 52,894 | - | 13.8 | 42,901 | Common Stock |
| Entrada Therapeutics Inc | Peter S. Kim | Director | Purchase of securities on an exchange or from another person at price $ 13.64 per share. | 22 Mar 2024 | 2,750 | 58,824 | - | 13.6 | 37,509 | Common Stock |
| Entrada Therapeutics Inc | Peter S. Kim | Director | Purchase of securities on an exchange or from another person at price $ 12.66 per share. | 19 Mar 2024 | 1,128 | 49,072 | - | 12.7 | 14,281 | Common Stock |
| Entrada Therapeutics Inc | Peter S. Kim | Director | Purchase of securities on an exchange or from another person at price $ 12.66 per share. | 19 Mar 2024 | 900 | 47,944 | - | 12.7 | 11,397 | Common Stock |
| Entrada Therapeutics Inc | Peter S. Kim | Director | Purchase of securities on an exchange or from another person at price $ 13.24 per share. | 19 Mar 2024 | 704 | 49,776 | - | 13.2 | 9,318 | Common Stock |
| Entrada Therapeutics Inc | Peter S. Kim | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 16,000 | 16,000 | - | - | Stock Option (Right to Buy) | |
| Entrada Therapeutics Inc | Peter S. Kim | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 11,918 | 11,918 | - | - | Stock Option (Right to Buy) | |
| Entrada Therapeutics Inc | Peter S. Kim | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Oct 2021 | 11,918 | 11,918 | - | - | Stock Option (Right to Buy) |